Extracorporeal Life Support
142 results
1 - 100Extracorporeal Life Support
- Introduction
- Outcomes
- Epidemiology
- Research and Future Directions
- Perspectives and Commentary
- Additional Resources
- Discussion Questions and Cases
- References
- Media
- Origen venovenous cannulas
- guidelines to venoarterial cannula
- guidelines to venovenous cannula
- cardiac ECLS By diagnoses 0-30 days
- cardiac ECLS by diagnosis 30 Days to < 16 Years
- neonatal respiratory runs by diagnosis
- pediatric respiratory runs by diagnosis
- Basic Science
- Anatomy
- Medical Treatment
- Medical Decision Making
- Surgical Decision Making
- Steps of the Procedure
- Postoperative Care
- Complications
Extracorporeal Life Support
- Instructions
- According to Delaplain (J Pediatr Surg 52:2018, 2017 ), infants with CDH that are placed on extracorporeal life support have a
- Which of the following would be the best predictor of the need for extracorporeal life support (ECLS) support in this patient with CDH?
- The next best step in management of this CDH baby requiring ECMO support is
- When writing total parenteral nutrition orders for this infant with CDH on ECMO, the amount of daily protein required should be:
- The most likley diagnosis in this patient with pulmonary failure is
- As a survivor of ECMO, their neurodevelopmental outcome will be:
- The best initial method of extracorporeal membrane oygenation access for this patient is
- According to Boyle (Pediatr Crit Care Med 19:760, 2018), the incidence of behavioral problems following ECLS is
Cannulation for ECLS
Congenital Diaphragmatic Hernia
Respiratory Care
PSSAP 7
Congenital Diaphragmatic Hernia
- Which of the following would be the best predictor of the need for extracorporeal life support (ECLS) support in this patient with CDH?
- The best initial mode of respiratory support for this infant with CDH is
- The next best step in management of this CDH baby requiring ECMO support is
- What is this patient’s biggest risk factor for developing a postoperative chylothorax?
- When writing total parenteral nutrition orders for this infant with CDH on ECMO, the amount of daily protein required should be:
- According to Unegbu (Pediatrics 139, 2017), with regards to treatment of the underlying pulmonary hypertension, the use of phosphodiesterase type 5 (PDE5) inhibitors has been shown to
- According to Boyle (Pediatr Crit Care Med 19:760, 2018), the incidence of behavioral problems following ECLS is
- According to Delaplain (J Pediatr Surg 52:2018, 2017 ), infants with CDH that are placed on extracorporeal life support have a
February 2018 articles of interest
Arterial Thrombosis
Congenital Pulmonary Airway Malformations
Surgical Critical Care Articles of Interest
Transfusion and Coagulation Therapy
PSSAP 30
- What is this patient’s biggest risk factor for developing a postoperative chylothorax?
- When comparing center-level risk adjusted survival for patients with congenital diaphragmatic hernia requiring extracorporeal life support (ECLS), centers that performed significantly better than the median standard mortality were associated with higher use of
Care of the Surgical Neonate
Pulmonary Hypertension
STEPS presentations
Cardiovascular Physiology and Shock
Surgical Infection
Ethics
November 2018 articles of interest
Spaced learning 02-14-2021
PSSAP 22
PSSAP 10
PSSAP 16
Respiratory Care
PSSAP 21
PSSAP 17
Nutrition
Spaced learning 07-29-2018
PSSAP 15
PSSAP 29
PSSAP 24
PSSAP 14
PSSAP 9
Transfusion and Coagulation Therapy
PSSAP 25
PSSAP 18
Thoracic and Cardiovascular Trauma
April 2019 articles of interest
PSSAP 28